- Rodrigues SF, Granger DN. Blood cells and endothelial barrier function. Tissue Barriers. 2015;3(1–2):1. doi:https://doi.org/10.4161/21688370.2014.978720.
- Jernigan PL, Makley AT, Hoehn RS, Edwards MJ, Pritts TA. The role of sphingolipids in endothelial barrier function. Biol Chem. 2015;396(6–7):681–21. doi:https://doi.org/10.1515/hsz-2014-0305.
- Xiong Y, Hla T. S1P control of endothelial integrity. Curr Top Microbiol Immunol. 2014;378:85–105. doi:https://doi.org/10.1007/978-3-319-05879-5_4.
- Garcia JG, Liu F, Verin AD, Birukova A, Dechert MA, Gerthoffer WT, Bamberg JR, English D. Sphingosine 1-phosphate promotes endothelial cell barrier integrity by Edg-dependent cytoskeletal rearrangement. J Clin Invest. 2001;108(5):689–701. doi:https://doi.org/10.1172/JCI12450.
- Spiegel S, Milstien S. Sphingosine-1-phosphate: an enigmatic signalling lipid. Nat Rev Mol Cell Biol. 2003;4(5):397–407. doi:https://doi.org/10.1038/nrm1103.
- Camerer E, Regard JB, Cornelissen I, Srinivasan Y, Duong DN, Palmer D, Pham TH, Wong JS, Pappu R, Coughlin SR, et al. Sphingosine-1-phosphate in the plasma compartment regulates basal and inflammation-induced vascular leak in mice. J Clin Invest. 2009;119(7):1871–1879. doi:https://doi.org/10.1172/jci38575.
- Matloubian M, Lo CG, Cinamon G, Lesneski MJ, Xu Y, Brinkmann V, Allende ML, Proia RL, Cyster JG. Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature. 2004;427(6972):355–360. doi:https://doi.org/10.1038/nature02284.
- Walsh KB, Teijaro JR, Wilker PR, Jatzek A, Fremgen DM, Das SC, Watanabe T, Hatta M, Shinya K, Suresh M, et al. Suppression of cytokine storm with a sphingosine analog provides protection against pathogenic influenza virus. Proc Natl Acad Sci U S A. 2011;108(29):12018–12023. doi:https://doi.org/10.1073/pnas.1107024108.
- Pitson SM. Activation of sphingosine kinase 1 by ERK1/2-mediated phosphorylation. EMBO J. 2003;22(20):5491–5500. doi:https://doi.org/10.1093/emboj/cdg540.
- Hait NC, Bellamy A, Milstien S, Kordula T, Spiegel S. Sphingosine kinase type 2 activation by ERK-mediated phosphorylation. J Biol Chem. 2007;282:12058–12065. doi:https://doi.org/10.1074/jbc.M609559200.
- Maceyka M, Sankala H, Hait NC, Le Stunff H, Liu H, Toman R, Collier C, Zhang M, Satin LS, Merrill AH, et al. SphK1 and SphK2, sphingosine kinase isoenzymes with opposing functions in sphingolipid metabolism. J Biol Chem. 2005;280(44):37118–37129. doi:https://doi.org/10.1074/jbc.M502207200.
- Spiegel S, Milstien S. The outs and the ins of sphingosine-1-phosphate in immunity. Nat Rev Immunol. 2011;11(6):403–415. doi:https://doi.org/10.1038/nri2974.
- Hisano Y, Kobayashi N, Kawahara A, Yamaguchi A, Nishi T. The sphingosine 1-phosphate transporter, SPNS2, functions as a transporter of the phosphorylated form of the immunomodulating agent FTY720. J Biol Chem. 2011;286(3):1758–1766. doi:https://doi.org/10.1074/jbc.M110.171116.
- Hisano Y, Kobayashi N, Yamaguchi A, Nishi T, Holowka D. Mouse SPNS2 functions as a sphingosine-1-phosphate transporter in vascular endothelial cells. PLoS One. 2012;7(6):e38941. doi:https://doi.org/10.1371/journal.pone.0038941.
- Vu TM, Ishizu A-N, Foo JC, Toh XR, Zhang F, Whee DM, Torta F, Cazenave-Gassiot A, Matsumura T, Kim S, et al. Mfsd2b is essential for the sphingosine-1-phosphate export in erythrocytes and platelets. Nature. 2017;550(7677):524–528. doi:https://doi.org/10.1038/nature24053.
- Van Veldhoven PP. Sphingosine-1-phosphate lyase. Methods Enzymol. 2000;311:244–254.
- Mandala SM. Sphingosine-1-phosphate phosphatases. Prostaglandins Other Lipid Mediat. 2001;64(1–4):143–156. doi:https://doi.org/10.1016/S0090-6980(01)00111-3.
- Murata N, Sato K, Kon J, Tomura H, Yanagita M, Kuwabara A, UI M, Okajima F. Interaction of sphingosine 1-phosphate with plasma components, including lipoproteins, regulates the lipid receptor-mediated actions. Biochem J. 2000;352(3):809–815. doi:https://doi.org/10.1042/bj3520809.
- Liu Y, Wada R, Yamashita T, Mi Y, Deng C-X, Hobson JP, Rosenfeldt HM, Nava VE, Chae S-S, Lee M-J, et al. Edg-1, the G protein–coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation. J Clin Invest. 2000;106(8):951–961. doi:https://doi.org/10.1172/JCI10905.
- Allende ML, Yamashita T, Proia RL. G-protein-coupled receptor S1P1 acts within endothelial cells to regulate vascular maturation. Blood. 2003;102(10):3665–3667. doi:https://doi.org/10.1182/blood-2003-02-0460.
- Allende ML. Sphingosine-1-phosphate receptors and the development of the vascular system. Biochim Biophys Acta. 2002;1582(1–3):222–227. doi:https://doi.org/10.1016/S1388-1981(02)00175-0.
- Darland DC, D’Amore PA. Blood vessel maturation: vascular development comes of age. J Clin Invest. 1999;103(2):157–158. doi:https://doi.org/10.1172/JCI6127.
- Conway EM, Collen D, Carmeliet P. Molecular mechanisms of blood vessel growth. Cardiovasc Res. 2001;49:507–521. doi:https://doi.org/10.1016/S0008-6363(00)00281-9.
- Kono M, Mi Y, Liu Y, Sasaki T, Allende ML, Wu YP, Yamashita T, Proia RL. The sphingosine-1-phosphate receptors S1P1, S1P2, and S1P3 function coordinately during embryonic angiogenesis. J Biol Chem. 2004;279(28):29367–29373. doi:https://doi.org/10.1074/jbc.M403937200.
- Mizugishi K, Yamashita T, Olivera A, Miller GF, Spiegel S, Proia RL. Essential role for sphingosine kinases in neural and vascular development. Mol Cell Biol. 2005;25(24):11113–11121. doi:https://doi.org/10.1128/MCB.25.24.11113-11121.2005.
- Jeya Paul J, Weigel C, Muller T, Heller R, Spiegel S, Graler MH. Inflammatory Conditions Disrupt Constitutive Endothelial Cell Barrier Stabilization by Alleviating Autonomous Secretion of Sphingosine 1-Phosphate. Cells. 2020;9(4):928. doi:https://doi.org/10.3390/cells9040928.
- Sensken SC, Staubert C, Keul P, Levkau B, Schoneberg T, Graler MH. Selective activation of G alpha i mediated signalling of S1P3 by FTY720-phosphate. Cell Signal. 2008;20(6):1125–1133. doi:https://doi.org/10.1016/j.cellsig.2008.01.019.
- Allard J, Barron S, Diaz J, Lubetzki C, Zalc B, Schwartz JC, Sokoloff P. A rat G protein-coupled receptor selectively expressed in myelin-forming cells. Eur J Neurosci. 1998;10(3):1045–1053. doi:https://doi.org/10.1046/j.1460-9568.1998.00117.x.
- Im D-S, Heise CE, Ancellin N, O’Dowd BF, Shei G-J, Heavens RP, Rigby MR, Hla T, Mandala S, McAllister G, et al. Characterization of a novel sphingosine 1-phosphate receptor, Edg-8. J Biol Chem. 2000;275(19):14281–14286. doi:https://doi.org/10.1074/jbc.275.19.14281.
- Im DS, Clemens J, Macdonald TL, Lynch KR. Characterization of the human and mouse sphingosine 1-phosphate receptor, S1P5 (Edg-8): structure-activity relationship of sphingosine1-phosphate receptors. Biochemistry. 2001;40:14053–14060. doi:https://doi.org/10.1021/bi011606i.
- Blaho VA, Hla T. An update on the biology of sphingosine 1-phosphate receptors. J Lipid Res. 2014;55(8):1596–1608. doi:https://doi.org/10.1194/jlr.R046300.
- Lee J-F, Zeng Q, Ozaki H, Wang L, Hand AR, Hla T, Wang E, Lee M-J. Dual roles of tight junction-associated protein, zonula occludens-1, in sphingosine 1-phosphate-mediated endothelial chemotaxis and barrier integrity. J Biol Chem. 2006;281(39):29190–29200. doi:https://doi.org/10.1074/jbc.M604310200.
- Argraves KM, Gazzolo PJ, Groh EM, Wilkerson BA, Matsuura BS, Twal WO, Hammad SM, Argraves WS. High density lipoprotein-associated sphingosine 1-phosphate promotes endothelial barrier function. J Biol Chem. 2008;283(36):25074–25081. doi:https://doi.org/10.1074/jbc.M801214200.
- McVerry BJ, Garcia JG. In vitro and in vivo modulation of vascular barrier integrity by sphingosine 1-phosphate: mechanistic insights. Cell Signal. 2005;17(2):131–139. doi:https://doi.org/10.1016/j.cellsig.2004.08.006.
- Singleton PA, Dudek SM, Chiang ET, Garcia JG. Regulation of sphingosine 1-phosphate-induced endothelial cytoskeletal rearrangement and barrier enhancement by S1P1 receptor, PI3 kinase, Tiam1/Rac1, and alpha-actinin. FASEB J. 2005;19:1646–1656. doi:https://doi.org/10.1096/fj.05-3928com.
- Singleton PA, Chatchavalvanich S, Fu P, Xing J, Birukova AA, Fortune JA, Klibanov AM, Garcia JGN, Birukov KG. Akt-Mediated Transactivation of the S1P1 Receptor in Caveolin-Enriched Microdomains Regulates Endothelial Barrier Enhancement by Oxidized Phospholipids. Circ Res. 2009;104(8):978–986. doi:https://doi.org/10.1161/CIRCRESAHA.108.193367.
- Shikata Y, Birukov KG, Birukova AA, Verin A, Garcia JG. Involvement of site-specific FAK phosphorylation in sphingosine-1 phosphate- and thrombin-induced focal adhesion remodeling: role of Src and GIT. FASEB J. 2003;17(15):2240–2249. doi:https://doi.org/10.1096/fj.03-0198com.
- Shikata Y, Birukov KG, Garcia JG. S1P induces FA remodeling in human pulmonary endothelial cells: role of Rac, GIT1, FAK, and paxillin. J Appl Physiol. 1985;2003:1193–1203.
- Belvitch P, Dudek SM. Role of FAK in S1P-regulated endothelial permeability. Microvasc Res. 2012;83(1):22–30. doi:https://doi.org/10.1016/j.mvr.2011.08.012.
- Dudek SM, Chiang ET, Camp SM, Guo Y, Zhao J, Brown ME, Singleton PA, Wang L, Desai A, Arce FT, et al. Abl tyrosine kinase phosphorylates nonmuscle Myosin light chain kinase to regulate endothelial barrier function. Mol Biol Cell. 2010;21(22):4042–4056. doi:https://doi.org/10.1091/mbc.e09-10-0876.
- Gao F, Sabbineni H, Artham S, Somanath PR. Modulation of long-term endothelial-barrier integrity is conditional to the cross-talk between Akt and Src signaling. J Cell Physiol. 2017;232(10):2599–2609. doi:https://doi.org/10.1002/jcp.25791.
- Klomp JE, Shaaya M, Matsche J, Rebiai R, Aaron JS, Collins KB, Huyot V, Gonzalez AM, Muller WA, Chew T-L, et al. Time-Variant SRC Kinase Activation Determines Endothelial Permeability Response. Cell Chem Biol. 2019;26(8):1081–94 e6. doi:https://doi.org/10.1016/j.chembiol.2019.04.007.
- Krump-Konvalinkova V, Yasuda S, Rubic T, Makarova N, Mages J, Erl W, Vosseler C, Kirkpatrick CJ, Tigyi G, Siess W, et al. Stable Knock-Down of the Sphingosine 1-Phosphate Receptor S1P 1 Influences Multiple Functions of Human Endothelial Cells. Arterioscler Thromb Vasc Biol. 2005;25(3):546–552. doi:https://doi.org/10.1161/01.ATV.0000154360.36106.d9.
- Sanchez T, Skoura A, Wu MT, Casserly B, Harrington EO, Hla T. Induction of Vascular Permeability by the Sphingosine-1-Phosphate Receptor–2 (S1P2R) and its Downstream Effectors ROCK and PTEN. Arterioscler Thromb Vasc Biol. 2007;27(6):1312–1318. doi:https://doi.org/10.1161/ATVBAHA.107.143735.
- Zhang G, Yang L, Kim GS, Ryan K, Lu S, O’Donnell RK, Spokes K, Shapiro N, Aird WC, Kluk MJ, et al. Critical role of sphingosine-1-phosphate receptor 2 (S1PR2) in acute vascular inflammation. Blood. 2013;122(3):443–455. doi:https://doi.org/10.1182/blood-2012-11-467191.
- Reinhard NR, Mastop M, Yin T, Wu Y, Bosma EK, Gadella TWJ Jr., Goedhart J, Hordijk PL. The balance between Gαi-Cdc42/Rac and Gα12/13-RhoA pathways determines endothelial barrier regulation by sphingosine-1-phosphate. Mol Biol Cell. 2017;28(23):3371–3382. doi:https://doi.org/10.1091/mbc.e17-03-0136.
- Medzhitov R. Origin and physiological roles of inflammation. Nature. 2008;454(7203):428–435. doi:https://doi.org/10.1038/nature07201.
- Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. doi:https://doi.org/10.1016/S0140-6736(20)30183-5.
- Marfia G, Navone S, Guarnaccia L, Campanella R, Mondoni M, Locatelli M, Barassi A, Fontana L, Palumbo F, Garzia E, et al. Decreased serum level of sphingosine-1-phosphate: a novel predictor of clinical severity in COVID-19. EMBO Mol Med. 2021;13(1):e13424. doi:https://doi.org/10.15252/emmm.202013424.
- Song J-W, Lam SM, Fan X, Cao W-J, Wang S-Y, Tian H, Chua GH, Zhang C, Meng F-P, Xu Z, et al. Omics-Driven Systems Interrogation of Metabolic Dysregulation in COVID-19 Pathogenesis. Cell Metab. 2020;32(2):188–202 e5. doi:https://doi.org/10.1016/j.cmet.2020.06.016.
- Thomas T, Stefanoni D, Dzieciatkowska M, Issaian A, Nemkov T, Hill RC, Francis RO, Hudson KE, Buehler PW, Zimring JC, et al. Evidence of Structural Protein Damage and Membrane Lipid Remodeling in Red Blood Cells from COVID-19 Patients. J Proteome Res. 2020;19(11):4455–4469. doi:https://doi.org/10.1021/acs.jproteome.0c00606.
- Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun. 2020;109:102433. doi:https://doi.org/10.1016/j.jaut.2020.102433.
- Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: summary of a Report of 72314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239–1242. doi:https://doi.org/10.1001/jama.2020.2648.
- Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, Mehra MR, Schuepbach RA, Ruschitzka F, Moch H, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395(10234):1417–1418. doi:https://doi.org/10.1016/S0140-6736(20)30937-5.
- McGowan EM, Haddadi N, Nassif NT, Lin Y. Targeting the SphK-S1P-SIPR Pathway as a Potential Therapeutic Approach for COVID-19. Int J Mol Sci. 2020;21(19):21. doi:https://doi.org/10.3390/ijms21197189.
- Winkler MS, Nierhaus A, Holzmann M, Mudersbach E, Bauer A, Robbe L, Zahrte C, Geffken M, Peine S, Schwedhelm E, et al. Decreased serum concentrations of sphingosine-1-phosphate in sepsis. Critical Care. 2015;19(1):372. doi:https://doi.org/10.1186/s13054-015-1089-0.
- Zhao J, Tan Y, Wang L, Su X, Shi Y. Serum sphingosine-1-phosphate levels and Sphingosine-1-Phosphate gene polymorphisms in acute respiratory distress syndrome: a multicenter prospective study. J Transl Med. 2020;18:156. doi:https://doi.org/10.1186/s12967-020-02322-y.
- Piotti A, Novelli D, Meessen J, Ferlicca D, Coppolecchia S, Marino A, Salati G, Savioli M, Grasselli G, Bellani G, et al. Endothelial damage in septic shock patients as evidenced by circulating syndecan-1, sphingosine-1-phosphate and soluble VE-cadherin: a substudy of ALBIOS. Critical Care. 2021;25(1):113. doi:https://doi.org/10.1186/s13054-021-03545-1.
- Hemdan NY, Weigel C, Reimann C-M, Graler MH. Modulating sphingosine 1-phosphate signaling with DOP or FTY720 alleviates vascular and immune defects in mouse sepsis. Eur J Immunol. 2016;46(12):2767–2777. doi:https://doi.org/10.1002/eji.201646417.
- Wang Z, Sims CR, Patil NK, Gokden N, Mayeux PR. Pharmacologic targeting of sphingosine-1-phosphate receptor 1 improves the renal microcirculation during sepsis in the mouse. J Pharmacol Exp Ther. 2015;352(1):61–66. doi:https://doi.org/10.1124/jpet.114.219394.
- Flemming S, Burkard N, Meir M, Schick MA, Germer C-T, Schlegel N. Sphingosine-1-Phosphate Receptor-1 Agonist Sew2871 Causes Severe Cardiac Side Effects and Does Not Improve Microvascular Barrier Breakdown in Sepsis. Shock. 2018;49(1):71–81. doi:https://doi.org/10.1097/SHK.0000000000000908.
- Peng X, Hassoun PM, Sammani S, McVerry BJ, Burne MJ, Rabb H, Pearse D, Tuder RM, Garcia JGN. Protective effects of sphingosine 1-phosphate in murine endotoxin-induced inflammatory lung injury. Am J Respir Crit Care Med. 2004;169(11):1245–1251. doi:https://doi.org/10.1164/rccm.200309-1258OC.
- McVerry BJ, Peng X, Hassoun PM, Sammani S, Simon BA, Garcia JG. Sphingosine 1-phosphate reduces vascular leak in murine and canine models of acute lung injury. Am J Respir Crit Care Med. 2004;170(9):987–993. doi:https://doi.org/10.1164/rccm.200405-684OC.
- Suryadevara V, Fu P, Ebenezer DL, Berdyshev E, Bronova IA, Huang LS, Harijith A, Natarajan V. Sphingolipids in Ventilator Induced Lung Injury: role of Sphingosine-1-Phosphate Lyase. Int J Mol Sci. 2018;19(1):114. doi:https://doi.org/10.3390/ijms19010114.
- Spieth PM, Bluth T, Gama De Abreu M, Bacelis A, Goetz AE, Kiefmann R. Mechanotransduction in the lungs. Minerva anestesiologica. 2014;80:933–941.
- Sammani S, Moreno-Vinasco L, Mirzapoiazova T, Singleton PA, Chiang ET, Evenoski CL, Wang T, Mathew B, Husain A, Moitra J, et al. Differential Effects of Sphingosine 1–Phosphate Receptors on Airway and Vascular Barrier Function in the Murine Lung. Am J Respir Cell Mol Biol. 2010;43(4):394–402. doi:https://doi.org/10.1165/rcmb.2009-0223OC.
- Zhao Y, Gorshkova IA, Berdyshev E, He D, Fu P, Ma W, Su Y, Usatyuk PV, Pendyala S, Oskouian B, et al. Protection of LPS-induced murine acute lung injury by sphingosine-1-phosphate lyase suppression. Am J Respir Cell Mol Biol. 2011;45(2):426–435. doi:https://doi.org/10.1165/rcmb.2010-0422OC.
- Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, Colagiuri S, Guariguata L, Motala AA, Ogurtsova K, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract. 2019;157:107843. doi:https://doi.org/10.1016/j.diabres.2019.107843.
- Wigger D, Schumacher F, Schneider-Schaulies S, Kleuser B. Sphingosine 1-phosphate metabolism and insulin signaling. Cell Signal. 2021;82:109959. doi:https://doi.org/10.1016/j.cellsig.2021.109959.
- Petersen MC, Shulman GI. Mechanisms of Insulin Action and Insulin Resistance. Physiol Rev. 2018;98(4):2133–2223. doi:https://doi.org/10.1152/physrev.00063.2017.
- Leguina-Ruzzi A, Pereira J, Pereira-Flores K, Valderas JP, Mezzano D, Velarde V, Sáez CG. Increased RhoA/Rho-Kinase Activity and Markers of Endothelial Dysfunction in Young Adult Subjects with Metabolic Syndrome. Metab Syndr Relat Disord. 2015;13(9):373–380. doi:https://doi.org/10.1089/met.2015.0061.
- Alberti KG, Zimmet P, Shaw J. Metabolic syndrome-a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med. 2006;23(5):469–480. doi:https://doi.org/10.1111/j.1464-5491.2006.01858.x.
- Singh A, Ramnath RD, Foster RR, Wylie EC, Friden V, Dasgupta I, Haraldsson B, Welsh GI, Mathieson PW, Satchell SC, et al. Reactive oxygen species modulate the barrier function of the human glomerular endothelial glycocalyx. PLoS One. 2013;8(2):e55852. doi:https://doi.org/10.1371/journal.pone.0055852.
- Shi Y, Vanhoutte PM. Macro- and microvascular endothelial dysfunction in diabetes. J Diabetes. 2017;9:434–449.
- Sajja RK, Prasad S, Cucullo L. Impact of altered glycaemia on blood-brain barrier endothelium: an in vitro study using the hCMEC/D3 cell line. Fluids and Barriers of the CNS. 2014;11(1):8. doi:https://doi.org/10.1186/2045-8118-11-8.
- Tien T, Barrette KF, Chronopoulos A, Roy S. Effects of high glucose-induced Cx43 downregulation on occludin and ZO-1 expression and tight junction barrier function in retinal endothelial cells. Invest Ophthalmol Vis Sci. 2013;54(10):6518–6525. doi:https://doi.org/10.1167/iovs.13-11763.
- Laychock SG, Sessanna SM, Lin M-H, Mastrandrea LD. Sphingosine 1-Phosphate Affects Cytokine-Induced Apoptosis in Rat Pancreatic Islet β-Cells. Endocrinology. 2006;147(10):4705–4712. doi:https://doi.org/10.1210/en.2006-0456.
- Hasan NM, Longacre MJ, Stoker SW, Kendrick MA, Druckenbrod NR, Laychock SG, Mastrandrea LD, MacDonald MJ. Sphingosine kinase 1 knockdown reduces insulin synthesis and secretion in a rat insulinoma cell line. Arch Biochem Biophys. 2012;518(1):23–30. doi:https://doi.org/10.1016/j.abb.2011.11.016.
- Qi Y, Chen J, Lay A, Don A, Vadas M, Xia P. Loss of sphingosine kinase 1 predisposes to the onset of diabetes via promoting pancreatic β-cell death in diet-induced obese mice. FASEB J. 2013;27(10):4294–4304. doi:https://doi.org/10.1096/fj.13-230052.
- Liu Y, Harashima S-I, Wang Y, Suzuki K, Tokumoto S, Usui R, Tatsuoka H, Tanaka D, Yabe D, Harada N, et al. Sphingosine kinase 1–interacting protein is a dual regulator of insulin and incretin secretion. FASEB J. 2019;33(5):6239–6253. doi:https://doi.org/10.1096/fj.201801783RR.
- Ravichandran S, Finlin BS, Kern PA, Ozcan S. Sphk2−/− mice are protected from obesity and insulin resistance. Biochim Biophys Acta Mol Basis Dis. 2019;1865(3):570–576. doi:https://doi.org/10.1016/j.bbadis.2018.12.012.
- Song Z, Wang W, Li N, Yan S, Rong K, Lan T, Xia P. Sphingosine kinase 2 promotes lipotoxicity in pancreatic β-cells and the progression of diabetes. FASEB J. 2019;33(3):3636–3646. doi:https://doi.org/10.1096/fj.201801496R.
- Aji G, Huang Y, Ng ML, Wang W, Lan T, Li M, Li Y, Chen Q, Li R, Yan S, et al. Regulation of hepatic insulin signaling and glucose homeostasis by sphingosine kinase 2. Proc Natl Acad Sci U S A. 2020;117(39):24434–24442. doi:https://doi.org/10.1073/pnas.2007856117.
- Fang H, Feng Q, Shi Y, Zhou J, Wang Q, Zhong L. Hepatic insulin resistance induced by mitochondrial oxidative stress can be ameliorated by sphingosine 1-phosphate. Mol Cell Endocrinol. 2020;501:110660. doi:https://doi.org/10.1016/j.mce.2019.110660.
- Kurano M, Hara M, Tsuneyama K, Sakoda H, Shimizu T, Tsukamoto K, Ikeda H, Yatomi Y. Induction of insulin secretion by apolipoprotein M, a carrier for sphingosine 1-phosphate. Biochim Biophys Acta. 2014;1841(9):1217–1226. doi:https://doi.org/10.1016/j.bbalip.2014.05.002.
- Kurano M, Tsukamoto K, Shimizu T, Kassai H, Nakao K, Aiba A, Hara M, Yatomi Y. Protection Against Insulin Resistance by Apolipoprotein M/Sphingosine-1-Phosphate. Diabetes. 2020;69(5):867–881. doi:https://doi.org/10.2337/db19-0811.
- Fayyaz S, Henkel J, Japtok L, Kramer S, Damm G, Seehofer D, Püschel GP, Kleuser B. Involvement of sphingosine 1-phosphate in palmitate-induced insulin resistance of hepatocytes via the S1P2 receptor subtype. Diabetologia. 2014;57(2):373–382. doi:https://doi.org/10.1007/s00125-013-3123-6.
- Sanchez T, Estrada-Hernandez T, Paik J-H, Wu M-T, Venkataraman K, Brinkmann V, Claffey K, Hla T. Phosphorylation and action of the immunomodulator FTY720 inhibits vascular endothelial cell growth factor-induced vascular permeability. J Biol Chem. 2003;278(47):47281–47290. doi:https://doi.org/10.1074/jbc.M306896200.
- Kappos L, Antel J, Comi G, Montalban X, O’Connor P, Polman CH, Haas T, Korn AA, Karlsson G, Radue EW, et al. Oral fingolimod (FTY720) for relapsing multiple sclerosis. N Engl J Med. 2006;355(11):1124–1140. doi:https://doi.org/10.1056/NEJMoa052643.
- Pelletier D, Hafler DA. Fingolimod for multiple sclerosis. N Engl J Med. 2012;366(4):339–347. doi:https://doi.org/10.1056/NEJMct1101691.
- Nishihara H, Shimizu F, Sano Y, Takeshita Y, Maeda T, Abe M, Koga M, Kanda T. Fingolimod prevents blood-brain barrier disruption induced by the sera from patients with multiple sclerosis. PLoS One. 2015;10(3):e0121488. doi:https://doi.org/10.1371/journal.pone.0121488.
- Nishihara H, Maeda T, Sano Y, Ueno M, Okamoto N, Takeshita Y, Shimizu F, Koga M, Kanda T. Fingolimod promotes blood-nerve barrier properties in vitro. Brain and Behavior. 2018;8(4):e00924. doi:https://doi.org/10.1002/brb3.924.
- Annunziata P, Cioni C, Masi G, Tassi M, Marotta G, Severi S. Fingolimod reduces circulating tight-junction protein levels and in vitro peripheral blood mononuclear cells migration in multiple sclerosis patients. Sci Rep. 2018;8(1):15371. doi:https://doi.org/10.1038/s41598-018-33672-9.
- Wang L, Chiang ET, Simmons JT, Garcia JG, Dudek SM. FTY720-induced human pulmonary endothelial barrier enhancement is mediated by c-Abl. Eur Respir J. 2011;38(1):78–88. doi:https://doi.org/10.1183/09031936.00047810.
- Krump-Konvalinkova V, Chwalla I, Siess W. FTY720 inhibits S1P-mediated endothelial healing: relationship to S1P1-receptor surface expression. Biochem Biophys Res Commun. 2008;370(4):603–608. doi:https://doi.org/10.1016/j.bbrc.2008.03.144.
- Shea BS, Brooks SF, Fontaine BA, Chun J, Luster AD, Tager AM. Prolonged Exposure to Sphingosine 1–Phosphate Receptor-1 Agonists Exacerbates Vascular Leak, Fibrosis, and Mortality after Lung Injury. Am J Respir Cell Mol Biol. 2010;43(6):662–673. doi:https://doi.org/10.1165/rcmb.2009-0345OC.
- Wang L, Sammani S, Moreno-Vinasco L, Letsiou E, Wang T, Camp SM, Bittman R, Garcia JGN, Dudek SM. FTY720 (s)-phosphonate preserves sphingosine 1-phosphate receptor 1 expression and exhibits superior barrier protection to FTY720 in acute lung injury. Crit Care Med. 2014;42(3):e189–99. doi:https://doi.org/10.1097/CCM.0000000000000097.
- Oo ML, Chang S-H, Thangada S, Wu M-T, Rezaul K, Blaho V, Hwang S-I, Han DK, Hla T. Engagement of S1P1-degradative mechanisms leads to vascular leak in mice. J Clin Invest. 2011;121(6):2290–2300. doi:https://doi.org/10.1172/JCI45403.
- Camp SM, Bittman R, Chiang ET, Moreno-Vinasco L, Mirzapoiazova T, Sammani S, Lu X, Sun C, Harbeck M, Roe M, et al. Synthetic analogs of FTY720 [2-amino-2-(2-[4-octylphenyl]ethyl)-1,3-propanediol] differentially regulate pulmonary vascular permeability in vivo and in vitro. J Pharmacol Exp Ther. 2009;331(1):54–64. doi:https://doi.org/10.1124/jpet.109.153544.
- Camp SM, Chiang ET, Sun C, Usatyuk PV, Bittman R, Natarajan V, Garcia JGN, Dudek SM. Pulmonary endothelial cell barrier enhancement by novel FTY720 analogs: methoxy-FTY720, fluoro-FTY720, and beta-glucuronide-FTY720. Chem Phys Lipids. 2015;191:16–24. doi:https://doi.org/10.1016/j.chemphyslip.2015.08.004.
- Tauseef M, Kini V, Knezevic N, Brannan M, Ramchandaran R, Fyrst H, Saba J, Vogel SM, Malik AB, Mehta D, et al. Activation of sphingosine kinase-1 reverses the increase in lung vascular permeability through sphingosine-1-phosphate receptor signaling in endothelial cells. Circ Res. 2008;103(10):1164–1172. doi:https://doi.org/10.1161/01.RES.0000338501.84810.51.
- Li X, Stankovic M, Bonder CS, Hahn CN, Parsons M, Pitson SM, Xia P, Proia RL, Vadas MA, Gamble JR, et al. Basal and angiopoietin-1-mediated endothelial permeability is regulated by sphingosine kinase-1. Blood. 2008;111(7):3489–3497. doi:https://doi.org/10.1182/blood-2007-05-092148.
- Liang J, Nagahashi M, Kim EY, Harikumar KB, Yamada A, Huang W-C, Hait N, Allegood J, Price M, Avni D, et al. Sphingosine-1-phosphate links persistent STAT3 activation, chronic intestinal inflammation, and development of colitis-associated cancer. Cancer Cell. 2013;23(1):107–120. doi:https://doi.org/10.1016/j.ccr.2012.11.013.
- Kharel Y, Raje M, Gao M, Gellett AM, Tomsig JL, Lynch KR, Santos W. Sphingosine kinase type 2 inhibition elevates circulating sphingosine 1-phosphate. Biochem J. 2012;447(1):149–157. doi:https://doi.org/10.1042/BJ20120609.
- Dimasi DP, Pitson SM, Bonder CS. Examining the Role of Sphingosine Kinase-2 in the Regulation of Endothelial Cell Barrier Integrity. Microcirculation. 2016;23(3):248–265. doi:https://doi.org/10.1111/micc.12271.
- Fukuhara S, Simmons S, Kawamura S, Inoue A, Orba Y, Tokudome T, Sunden Y, Arai Y, Moriwaki K, Ishida J, et al. The sphingosine-1-phosphate transporter Spns2 expressed on endothelial cells regulates lymphocyte trafficking in mice. J Clin Invest. 2012;122(4):1416–1426. doi:https://doi.org/10.1172/JCI60746.
- Fu P, Ebenezer DL, Berdyshev EV, Bronova IA, Shaaya M, Harijith A, Natarajan V. Role of Sphingosine Kinase 1 and S1P Transporter Spns2 in HGF-mediated Lamellipodia Formation in Lung Endothelium. J Biol Chem. 2016;291(53):27187–27203. doi:https://doi.org/10.1074/jbc.M116.758946.
- Tatin F, Renaud-Gabardos E, Godet AC, Hantelys F, Pujol F, Morfoisse F, Calise D, Viars F, Valet P, Masri B, et al. Apelin modulates pathological remodeling of lymphatic endothelium after myocardial infarction. JCI Insight. 2017;2(12):2. doi:https://doi.org/10.1172/jci.insight.93887.
- Spiegel S, Maczis MA, Maceyka M, Milstien S. New insights into functions of the sphingosine-1-phosphate transporter SPNS2. J Lipid Res. 2019;60(3):484–489. doi:https://doi.org/10.1194/jlr.S091959.
- Bussolino F, Di Renzo MF, Ziche M, Bocchietto E, Olivero M, Naldini L, Gaudino G, Tamagnone L, Coffer A, Comoglio PM, et al. Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J Cell Biol. 1992;119(3):629–641. doi:https://doi.org/10.1083/jcb.119.3.629.
- Ephstein Y, Singleton PA, Chen W, Wang L, Salgia R, Kanteti P, Dudek SM, Garcia JGN, Jacobson JR. Critical Role of S1PR1 and Integrin β4 in HGF/c-Met-mediated Increases in Vascular Integrity. J Biol Chem. 2013;288(4):2191–2200. doi:https://doi.org/10.1074/jbc.M112.404780.
- Duan H-F, Wu C-T, Lu Y, Wang H, Liu H-J, Zhang Q-W, Jia -X-X, Lu -Z-Z, Wang L-S. Sphingosine kinase activation regulates hepatocyte growth factor induced migration of endothelial cells. Exp Cell Res. 2004;298(2):593–601. doi:https://doi.org/10.1016/j.yexcr.2004.04.049.
- Fu P, Shaaya M, Harijith A, Jacobson JR, Karginov A, Natarajan V. Sphingolipids Signaling in Lamellipodia Formation and Enhancement of Endothelial Barrier Function. Curr Top Membr. 2018;82:1–31.
- Kobayashi N, Kawasaki-Nishi S, Otsuka M, Hisano Y, Yamaguchi A, Nishi T. MFSD2B is a sphingosine 1-phosphate transporter in erythroid cells. Sci Rep. 2018;8(1):4969. doi:https://doi.org/10.1038/s41598-018-23300-x.
- Winkler MS, Martz KB, Nierhaus A, Daum G, Schwedhelm E, Kluge S, Gräler MH. Loss of sphingosine 1-phosphate (S1P) in septic shock is predominantly caused by decreased levels of high-density lipoproteins (HDL). J Intensive Care. 2019;7(1):23. doi:https://doi.org/10.1186/s40560-019-0376-2.
- Wilkerson BA, Grass GD, Wing SB, Argraves WS, Argraves KM. Sphingosine 1-phosphate (S1P) carrier-dependent regulation of endothelial barrier: high density lipoprotein (HDL)-S1P prolongs endothelial barrier enhancement as compared with albumin-S1P via effects on levels, trafficking, and signaling of S1P1. J Biol Chem. 2012;287(53):44645–44653. doi:https://doi.org/10.1074/jbc.M112.423426.
- Wilkerson BA, Argraves KM. The role of sphingosine-1-phosphate in endothelial barrier function. Biochim Biophys Acta. 2014;1841(10):1403–1412. doi:https://doi.org/10.1016/j.bbalip.2014.06.012.
- Christoffersen C, Obinata H, Kumaraswamy SB, Galvani S, Ahnstrom J, Sevvana M, Egerer-Sieber C, Muller YA, Hla T, Nielsen LB, et al. Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M. Proc Natl Acad Sci U S A. 2011;108(23):9613–9618. doi:https://doi.org/10.1073/pnas.1103187108.
- Bisgaard LS, Christoffersen C. Apolipoprotein M/sphingosine-1-phosphate: novel effects on lipids, inflammation and kidney biology. Curr Opin Lipidol. 2019;30(3):212–217. doi:https://doi.org/10.1097/MOL.0000000000000606.
- Galvani S, Sanson M, Blaho VA, Swendeman SL, Obinata H, Conger H, Dahlbäck B, Kono M, Proia RL, Smith JD, et al. HDL-bound sphingosine 1-phosphate acts as a biased agonist for the endothelial cell receptor S1P1 to limit vascular inflammation. Sci Signal. 2015;8(389):ra79. doi:https://doi.org/10.1126/scisignal.aaa2581.
- Ruiz M, Frej C, Holmer A, Guo LJ, Tran S, Dahlback B. High-Density Lipoprotein–Associated Apolipoprotein M Limits Endothelial Inflammation by Delivering Sphingosine-1-Phosphate to the Sphingosine-1-Phosphate Receptor 1. Arterioscler Thromb Vasc Biol. 2017;37(1):118–129. doi:https://doi.org/10.1161/ATVBAHA.116.308435.
- Zhu B, Luo G-H, Feng Y-H, Yu -M-M, Zhang J, Wei J, Yang C, Xu N, Zhang X-Y. Apolipoprotein M protects against lipopolysaccharide-induced acute lung injury via sphingosine-1-phosphate signaling. Inflammation. 2018;41(2):643–653. doi:https://doi.org/10.1007/s10753-017-0719-x.
- Fan Y, Chen J, Liu D, Li W, Wang H, Huang Y, Gao C. HDL-S1P protects endothelial function and reduces lung injury during sepsis in vivo and in vitro. Int J Biochem Cell Biol. 2020;126:105819. doi:https://doi.org/10.1016/j.biocel.2020.105819.
- Swendeman SL, Xiong Y, Cantalupo A, Yuan H, Burg N, Hisano Y, Cartier A, Liu CH, Engelbrecht E, Blaho V, et al. An engineered S1P chaperone attenuates hypertension and ischemic injury. Sci Signal. 2017;10(492):eaal2722. doi:https://doi.org/10.1126/scisignal.aal2722.
- Burg N, Swendeman S, Worgall S, Hla T, Salmon JE. Sphingosine 1-Phosphate Receptor 1 Signaling Maintains Endothelial Cell Barrier Function and Protects Against Immune Complex-Induced Vascular Injury. Arthritis Rheumatol. 2018;70(11):1879–1889. doi:https://doi.org/10.1002/art.40558.
- Abbott NJ, Ronnback L, Hansson E. Astrocyte–endothelial interactions at the blood–brain barrier. Nat Rev Neurosci. 2006;7(1):41–53. doi:https://doi.org/10.1038/nrn1824.
- Obermeier B, Daneman R, Ransohoff RM. Development, maintenance and disruption of the blood-brain barrier. Nat Med. 2013;19(12):1584–1596. doi:https://doi.org/10.1038/nm.3407.
- Van Doorn R, Lopes Pinheiro MA, Kooij G, Lakeman K, van het Hof B, Van Der Pol SM, Geerts D, van Horssen J, van der Valk P, van der Kam E, et al. Sphingosine 1-phosphate receptor 5 mediates the immune quiescence of the human brain endothelial barrier. J Neuroinflammation. 2012;9(1):133. doi:https://doi.org/10.1186/1742-2094-9-133.
- Li Y-J, Shi SX, Liu Q, Shi F-D, Gonzales RJ. Targeted role for sphingosine-1-phosphate receptor 1 in cerebrovascular integrity and inflammation during acute ischemic stroke. Neurosci Lett. 2020;735:135160. doi:https://doi.org/10.1016/j.neulet.2020.135160.
- Yanagida K, Liu CH, Faraco G, Galvani S, Smith HK, Burg N, Anrather J, Sanchez T, Iadecola C, Hla T, et al. Size-selective opening of the blood-brain barrier by targeting endothelial sphingosine 1-phosphate receptor 1. Proc Natl Acad Sci U S A. 2017;114(17):4531–4536. doi:https://doi.org/10.1073/pnas.1618659114.
- Spampinato SF, Merlo S, Sano Y, Kanda T, Sortino MA. Protective effect of the sphingosine-1 phosphate receptor agonist siponimod on disrupted blood brain barrier function. Biochem Pharmacol. 2021;186:114465. doi:https://doi.org/10.1016/j.bcp.2021.114465.
- Stepanovska B, Lange AI, Schwalm S, Pfeilschifter J, Coldewey SM, Huwiler A. Downregulation of S1P Lyase Improves Barrier Function in Human Cerebral Microvascular Endothelial Cells Following an Inflammatory Challenge. Int J Mol Sci. 2020;21(4):1240. doi:https://doi.org/10.3390/ijms21041240.
- Gude NM, Roberts CT, Kalionis B, King RG. Growth and function of the normal human placenta. Thromb Res. 2004;114(5–6):397–407. doi:https://doi.org/10.1016/j.thromres.2004.06.038.
- Del Gaudio I, Sreckovic I, Zardoya-Laguardia P, Bernhart E, Christoffersen C, Frank S, Marsche G, Illanes SE, Wadsack C. Circulating cord blood HDL-S1P complex preserves the integrity of the feto-placental vasculature. Biochim Biophys Acta Mol Cell Biol Lipids. 2020;1865(4):158632. doi:https://doi.org/10.1016/j.bbalip.2020.158632.
- Hemmings DG, Hudson NK, Halliday D, O’Hara M, Baker PN, Davidge ST, Taggart MJ. Sphingosine-1-phosphate acts via rho-associated kinase and nitric oxide to regulate human placental vascular tone. Biol Reprod. 2006;74(1):88–94. doi:https://doi.org/10.1095/biolreprod.105.043034.
- Del Gaudio I, Sasset L, Lorenzo AD, Wadsack C. Sphingolipid Signature of Human Feto-Placental Vasculature in Preeclampsia. Int J Mol Sci. 2020;21(3):1019. doi:https://doi.org/10.3390/ijms21031019.
- Dobierzewska A, Palominos M, Sanchez M, Dyhr M, Helgert K, Venegas-Araneda P, Tong S, Illanes SE. Impairment of Angiogenic Sphingosine Kinase-1/Sphingosine-1-Phosphate Receptors Pathway in Preeclampsia. PLoS One. 2016;11(6):e0157221. doi:https://doi.org/10.1371/journal.pone.0157221.
- Del Gaudio I, Hendrix S, Christoffersen C, Wadsack WC. Neonatal HDL Counteracts Placental Vascular Inflammation via S1P–S1PR1 Axis. Int J Mol Sci. 2020;21(3):789. doi:https://doi.org/10.3390/ijms21030789.
Free access
Barrier maintenance by S1P during inflammation and sepsis
View further author information
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.